Sign in

CIK 0001808805

  • Non-accelerated filer
  • Smaller reporting company

Nautilus Biotechnology, Inc.

Sign in to watch
Ticker
NAUT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Entity type
Operating
EIN
981541723
Phone
+1 206-333-2001
Business address
2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
Former names
ARYA Sciences Acquisition Corp III
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-14 ALTMAN MICHAEL SETH Director Grant or award · Stock Option (Right to Buy) +45,000 45,000
2023-06-15 ALTMAN MICHAEL SETH Director Grant or award · Stock Option (Right to Buy) +45,000 45,000
2022-06-15 ALTMAN MICHAEL SETH Director Grant or award · Stock Option (Right to Buy) +86,467 86,467
2021-06-09 ALTMAN MICHAEL SETH Director Conversion +3,647,500 3,647,500
2021-06-09 ALTMAN MICHAEL SETH Director Conversion −499,000 0
2021-06-09 ALTMAN MICHAEL SETH Director Conversion +499,000 499,000
2021-06-09 ALTMAN MICHAEL SETH Director Conversion · Class B ordinary shares −3,647,500 0
2021-06-09 ALTMAN MICHAEL SETH Director Grant or award · Stock Option (Right to buy) +44,435 44,435
2020-08-11 ALTMAN MICHAEL SETH Chief Financial Officer Other acquisition +499,000 $10.00 $5.0M 499,000

Page 1 of 1 · 9 trades